From Grad Students to Groundbreakers

From Grad Students to GroundbreakersThe Grinstaff Group taps several disciplines to solve medical problems

In this series

  • Doctor Mark Grinstaff, professor of chemistry, Boston University College of Arts and Sciences, CAS, professor of biomedical and materials science engineering, Boston University College of Engineering, ENG, The Grinstaff Group, biomedical engineering research laboratory, Boston University biomedical research faculty, Boston University post graduate research

    Chapter 1 From Grad Students to Groundbreakers

    For 11 years, CAS and ENG prof Mark Grinstaff and the more than 20 graduate students and postdoctoral fellows in his Grinstaff Group have been combining their expertise in chemistry, pharmacology, and biomedical and mechanical engineering to tackle complicated medical challenges.

    Read More

  • The Grinstaff Group, chemotherapy drug delivery treatment for mesothelioma, nanoparticles, Doctor Mark Grinstaff, professor of chemistry, Boston University College of Arts and Sciences, CAS, professor of biomedical and materials science engineering, Boston University College of Engineering, ENG, biomedical engineering research laboratory, Boston University biomedical research faculty, Boston University post graduate research, Boston University post-graduate research

    Chapter 2 Drug-Packed Nanoparticles KO Mesothelioma

    For 11 years, CAS and ENG prof Mark Grinstaff and the more than 20 graduate students and postdoctoral fellows in his Grinstaff Group have been combining their expertise in chemistry, pharmacology, and biomedical and mechanical engineering to tackle complicated medical challenges.

    Read More

  • water resistant polymer mesh, mesh film chemotherapy drug delivery system, early stage lung cancer, The Grinstaff Group, biomedical engineering research laboratory, Boston University biomedical research faculty, Boston University post graduate research, Boston University post-graduate research, Doctor Mark Grinstaff, professor of chemistry, Boston University College of Arts and Sciences, CAS, professor of biomedical and materials science engineering, Boston University College of Engineering

    Chapter 3 High-Tech Mesh Delivers Chemo to Patients with Early-Stage Lung Cancer

    For 11 years, CAS and ENG prof Mark Grinstaff and the more than 20 graduate students and postdoctoral fellows in his Grinstaff Group have been combining their expertise in chemistry, pharmacology, and biomedical and mechanical engineering to tackle complicated medical challenges.

    Read More

  • osteoarthritis joint lubricant, osteoarthritis joint treatment, Grinstaff Group, biomedical engineering research laboratory, Boston University biomedical research faculty, Boston University post graduate research, Boston University post-graduate research, Doctor Mark Grinstaff, professor of chemistry, Boston University College of Arts and Sciences, CAS, professor of biomedical and materials science engineering, Boston University College of Engineering

    Chapter 4 A Better Way to Find and Treat Osteoarthritis

    An estimated 27 million Americans have osteoarthritis, a degenerative disease that destroys cartilage and underlying bone. BU's Grinstaff Group members are developing new technologies and treatments that could improve discovery and diagnosis—and slow the rush to joint replacement.

    Read More

View All Series